Monthly Archives: December 2016
How Can Pharma Leverage the Health Outcomes Liaison Function for Maximum Impact?
With the shift toward evidence-based medicine and value-based pricing in the health care industry, bio-pharmaceutical organizations have turned to Health Outcomes Liaisons (HOLs) to serve as a scientific bridge with payer organizations, thought leaders, and other important decision makers. It